Shield Therapeutics plc
SHIEF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 108.4% | 56% | 34% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 49.4% | 47.3% | 45% | 20.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -25.4% | -42.6% | -110.9% | -224.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -44.5% | -58.4% | -127.6% | -236.4% |
| EPS Diluted | -0.007 | -0.006 | -0.008 | -0.011 |
| % Growth | -17.9% | 28.2% | 31.6% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |